This inventor holds 34 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Genentech, Inc., Recurium IP Holdings, LLC, Seragon Pharmaceuticals, Inc.. Active years: 2006-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Baltimore, MD (US) (2006 - 2011)
- San Diego, CA (US) (2009 - 2022)
- La Jolla, CA (US) (2012 - 2022)
Company Filing History:
9 out of 3,300 
6 out of 30 
5 out of 6 
Years Active: 2006-2025
Areas of Expertise:
Title: Innovator Spotlight: Mehmet Kahraman
Introduction: Mehmet Kahraman, a prominent inventor based in La Jolla, California, has made significant contributions to the field of medical sciences, with a focus on innovative compounds and treatment methods. With an impressive portfolio of 34 patents, his research is paving the way for breakthroughs in the treatment of various diseases.
Latest Patents: Among his latest innovations, Kahraman has developed compounds and methods for treating oxalate-related diseases. His research discloses novel compounds and compositions aimed at modulating glycolate oxidase, which offers promising therapeutic strategies for conditions such as hyperoxaluria. Additionally, he has introduced anticancer compounds characterized as BDII-selective inhibitors of BET proteins, which are anticipated to have therapeutic potential in treating cancer, acute kidney disease, and viral infections.
Career Highlights: Throughout his career, Kahraman has worked for notable companies, including Genentech, Inc. and Recurium IP Holdings, LLC. These positions not only highlight his expertise in pharmaceuticals but underscore his commitment to advancing medical research and innovation.
Collaborations: Collaborating with talented professionals has been a considerable aspect of Kahraman's success. He has worked alongside esteemed coworkers such as Steven P. Govek and Nicholas D. Smith, contributing to a collaborative environment that fosters groundbreaking discoveries in medicine.
Conclusion: Mehmet Kahraman's innovative spirit and dedication to improving human health exemplify the essence of modern inventors. With his extensive patent portfolio and collaborative efforts, he continues to lead the way in developing transformative treatments for various health challenges. His contributions not only impact the medical field but inspire future inventors in their pursuit of innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile